Hyeong‐jun Han

820 total citations
29 papers, 623 citations indexed

About

Hyeong‐jun Han is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Hyeong‐jun Han has authored 29 papers receiving a total of 623 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 11 papers in Oncology and 8 papers in Immunology. Recurrent topics in Hyeong‐jun Han's work include Signaling Pathways in Disease (5 papers), CRISPR and Genetic Engineering (5 papers) and Peptidase Inhibition and Analysis (5 papers). Hyeong‐jun Han is often cited by papers focused on Signaling Pathways in Disease (5 papers), CRISPR and Genetic Engineering (5 papers) and Peptidase Inhibition and Analysis (5 papers). Hyeong‐jun Han collaborates with scholars based in South Korea, United States and India. Hyeong‐jun Han's co-authors include Eunyoung Choi, Hollie I. Swanson, Kedra Cyrus, Hyosung Lee, Kyungbo Kim, Marie Wehenkel, Young‐Joon Surh, Jung‐Hyun Kim, Do‐Hee Kim and Bu Young Choi and has published in prestigious journals such as PLoS ONE, Scientific Reports and The FASEB Journal.

In The Last Decade

Hyeong‐jun Han

28 papers receiving 619 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hyeong‐jun Han South Korea 14 429 173 89 87 72 29 623
Hongwei Tang China 13 367 0.9× 105 0.6× 113 1.3× 53 0.6× 42 0.6× 38 573
Vitalba Ruggieri Italy 17 374 0.9× 109 0.6× 187 2.1× 65 0.7× 54 0.8× 29 650
Irit Snir-Alkalay Israel 5 416 1.0× 243 1.4× 108 1.2× 104 1.2× 46 0.6× 8 633
Steve McClellan United States 9 380 0.9× 321 1.9× 169 1.9× 101 1.2× 70 1.0× 11 771
Yanwen Zhou Japan 16 394 0.9× 158 0.9× 90 1.0× 119 1.4× 32 0.4× 34 618
Hexiao Wang China 10 346 0.8× 139 0.8× 134 1.5× 69 0.8× 56 0.8× 18 538
Yueping Sun China 12 330 0.8× 192 1.1× 101 1.1× 257 3.0× 42 0.6× 20 718
Suji Han South Korea 14 478 1.1× 222 1.3× 154 1.7× 84 1.0× 54 0.8× 29 752
Jing‐Yu Lang China 14 607 1.4× 202 1.2× 202 2.3× 71 0.8× 56 0.8× 23 803

Countries citing papers authored by Hyeong‐jun Han

Since Specialization
Citations

This map shows the geographic impact of Hyeong‐jun Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hyeong‐jun Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hyeong‐jun Han more than expected).

Fields of papers citing papers by Hyeong‐jun Han

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hyeong‐jun Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hyeong‐jun Han. The network helps show where Hyeong‐jun Han may publish in the future.

Co-authorship network of co-authors of Hyeong‐jun Han

This figure shows the co-authorship network connecting the top 25 collaborators of Hyeong‐jun Han. A scholar is included among the top collaborators of Hyeong‐jun Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hyeong‐jun Han. Hyeong‐jun Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Han, Hyeong‐jun & Hyunyoung Kim. (2025). 3D alveolar organoid drug screening model for targeting TGF-β1 in pulmonary fibrosis. Biochemistry and Biophysics Reports. 43. 102191–102191.
2.
Han, Hyeong‐jun & Jung‐Hyun Kim. (2024). KSCBi005-A-10(hiPSC-HIF1αKO), a HIF1α knockout human induced pluripotent stem cell line, for demonstrating the role of cellular response to hypoxia. Stem Cell Research. 77. 103415–103415. 1 indexed citations
3.
Han, Hyeong‐jun & Jung‐Hyun Kim. (2023). KSCBi005-A-8(hiPSC-PD-L1KO), a PD-L1 knockout human induced pluripotent stem cell line for demonstrating the role of the PD-1/PD-L1 axis. Stem Cell Research. 72. 103196–103196. 1 indexed citations
4.
Kim, Min Jung, Su-Mi Kim, Hyeong‐jun Han, et al.. (2023). Reciprocal enhancement of SARS-CoV-2 and influenza virus replication in human pluripotent stem cell-derived lung organoids. Emerging Microbes & Infections. 12(1). 2211685–2211685. 21 indexed citations
5.
Han, Hyeong‐jun, Jee Young Sung, Un-Jung Yun, et al.. (2021). Fibronectin regulates anoikis resistance via cell aggregate formation. Cancer Letters. 508. 59–72. 89 indexed citations
6.
Han, Hyeong‐jun & Jung‐Hyun Kim. (2021). Establishment of a TLR3 homozygous knockout human induced pluripotent stem cell line using CRISPR/Cas9. Stem Cell Research. 52. 102187–102187. 2 indexed citations
7.
Han, Hyeong‐jun, et al.. (2021). Alternative regulation of HIF-1α stability through Phosphorylation on Ser451. Biochemical and Biophysical Research Communications. 545. 150–156. 14 indexed citations
8.
Kim, Su‐Jung, Hyeong‐jun Han, Seung Hyeon Kim, et al.. (2021). Peptidyl‐prolyl cis‐trans isomerase NIMA‐interacting 1 directly binds and stabilizes Nrf2 in breast cancer. The FASEB Journal. 36(1). e22068–e22068. 14 indexed citations
9.
Kim, Su‐Jung, Hyeong‐jun Han, Seong Hoon Kim, et al.. (2020). H-Ras induces Nrf2-Pin1 interaction: Implications for breast cancer progression. Toxicology and Applied Pharmacology. 402. 115121–115121. 8 indexed citations
10.
Han, Hyeong‐jun, Su‐Jung Kim, Do‐Hee Kim, et al.. (2020). The peptidyl prolyl isomerase, PIN1 induces angiogenesis through direct interaction with HIF-2α. Biochemical and Biophysical Research Communications. 533(4). 995–1003. 6 indexed citations
11.
Han, Hyeong‐jun, et al.. (2019). Generation of a TLR7 homozygous knockout human induced pluripotent stem cell line using CRISPR/Cas9. Stem Cell Research. 40. 101520–101520. 3 indexed citations
12.
Han, Hyeong‐jun, et al.. (2019). Generation of a KSCBi005-A-5(TLR8KO-A10) homozygous knockout human induced pluripotent stem cell line using CRISPR/Cas9. Stem Cell Research. 40. 101561–101561. 4 indexed citations
13.
Han, Hyeong‐jun, Vincent Delorme, David Shum, et al.. (2019). Drug Discovery Platform Targeting M. tuberculosis with Human Embryonic Stem Cell-Derived Macrophages. Stem Cell Reports. 13(6). 980–991. 34 indexed citations
14.
Han, Hyeong‐jun, Kyung Oh Jung, Su‐Jung Kim, et al.. (2016). Peptidyl Prolyl Isomerase PIN1 Directly Binds to and Stabilizes Hypoxia-Inducible Factor-1α. PLoS ONE. 11(1). e0147038–e0147038. 26 indexed citations
15.
Liu, Baiwei, et al.. (2016). [Analysis of BPPV in patients with bone mineral density results].. PubMed. 30(23). 1865–1869;1872. 5 indexed citations
16.
Cyrus, Kedra, Marie Wehenkel, Eunyoung Choi, et al.. (2010). Impact of linker length on the activity of PROTACs. Molecular BioSystems. 7(2). 359–364. 161 indexed citations
17.
Kim, Tack‐Joong, Hyeong‐jun Han, Yong Lim, et al.. (2009). Antiproliferative Action of Cudraflavone B, Isolated From Cudrania tricuspidata, Through the Downregulation of pRb Phosphorylation in Aortic Smooth Muscle Cell Proliferation Signaling. Journal of Cardiovascular Pharmacology. 53(4). 341–348. 16 indexed citations
18.
19.
Han, Hyeong‐jun, Tack‐Joong Kim, Yong-Ri Jin, et al.. (2007). Cudraflavanone A, a Flavonoid Isolated from the Root Bark of Cudrania tricuspidata, Inhibits Vascular Smooth Muscle Cell Growth via an Akt-Dependent Pathway. Planta Medica. 73(11). 1163–1168. 12 indexed citations
20.
Jin, Yong-Ri, Jung‐Jin Lee, Jin‐Ho Chung, et al.. (2006). Antiplatelet and antithrombotic activities of Korean Red Ginseng. Archives of Pharmacal Research. 29(10). 898–903. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hongwei Tang Breakdown of academic impact, for papers by Vitalba Ruggieri Breakdown of academic impact, for papers by Irit Snir-Alkalay Breakdown of academic impact, for papers by Steve McClellan Breakdown of academic impact, for papers by Yanwen Zhou Breakdown of academic impact, for papers by Hexiao Wang Breakdown of academic impact, for papers by Yueping Sun Breakdown of academic impact, for papers by Suji Han Breakdown of academic impact, for papers by Jing‐Yu Lang
Rankless by CCL
2026